Skip to main content

Table 1 Baseline characteristics of the patients

From: Incidence and influence of prosthesis-patient mismatch after reoperative aortic valve replacement: a retrospective single-center study

 Total
(n = 113)
Repeat AVR
(n = 44)
Primary AVR
(n = 69)
p
Male (%)54 (47.8)22 (50)54 (78.3)0.85
Age (years)68.4 ± 12.870.4 ± 13.767.2 ± 12.10.2
Body mass index22.5 ± 4.122.7 ± 4.922.4 ± 3.60.68
Body surface area1.5 ± 0.21.5 ± 0.21.5 ± 0.20.81
Diabetes (%)26 (23)9 (20.5)17 (24.6)0.65
Hypertension (%)61 (54)26 (59.1)35 (50.7)0.44
Dyslipidemia (%)38 (33.6)14 (31.8)24 (34.8)0.84
Smoking history (%)30 (26.5)12 (27.3)18 (26.1)1
COPD (%)15 (13.3)7 (15.9)8 (11.6)0.58
Atrial fibrillation (%)20 (17.7)5 (11.4)15 (21.7)0.21
CVD (%)15 (13.3)3 (6.8)5 (7.2)1
Low LVEF < 40% (%)7 (6.2)3 (6.8)4 (5.8)1
Emergency (%)3 (2.7)2 (4.5)1 (1.4)0.56
Hemodialysis10 (8.8)5 (11.4)5 (7.2)0.51
Endocarditis12 (10.6)8 (18.2)4 (5.8)0.06
Aortic stenosis70 (61.9)23 (52.3)47 (68.1)0.11
Interval since last cardiac surgery (y)13.9 ± 9.411 ± 8.115.7 ± 9.80.01
Reoperations   0.33
 First reoperation102 (90.3)38 (86.4)64 (92.8) 
 Second reoperation11 (9.7)6 (13.6)5 (7.2) 
  1. AVR aortic valve replacement, COPD chronic obstructive pulmonary disease, CVD cerebrovascular disease, LVEF left ventricle ejection fraction